US 8465749
Polysaccharide-protein conjugate vaccines
granted A61KA61K2039/6037A61K2039/6087
Quick answer
US patent 8465749 (Polysaccharide-protein conjugate vaccines) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/6037, A61K2039/6087, A61K2039/627, A61K39/00